This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,347.53, is a delivery order for the provision of 4566566192 DUPIXENT 300 MG/2 ML SYRINGE 2ML. The contract has an ultimate completion date of November 29, 2024 and is a firm fixed-price arrangement. Notably, this award was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/26/25, 9:48 AM